BPC-157 exposure was associated with greater fibroblast outgrowth from tendon tissue, better cell survival under oxidative stress, more movement through a Transwell membrane, and greater cell spreading
Money Report Headline results from a REDEFINE-2 late-stage trial released earlier this month showed that CagriSema helped obese or overweight adult patients with type 2 diabetes lose 15.7% of their weight over 68 weeks, compared with 3.1% with placebo
Key takeaways Mounjaro is approved for type 2 diabetes, while Wegovy is approved for weight loss In clinical trials, patients taking tirzepatide (the active ingredient in Mounjaro) lost more weight on average than those taking semaglutide (the active ingredient in Wegovy) Both drugs have similar gastrointestinal side effects, but prices vary depending on your insurance status Mounjaro (tirzepatide) and Wegovy (semaglutide) are two medications that have gained a lot of attention in recent years
The frequency for microdosing is still daily in most protocols
PlexusDx compounded semaglutide injection removes cost barriers by charging a flat $189/mo (or $149/mo on the 6-month plan) rate regardless of dosemeaning you can increase your dose as needed without price increases
[Read More]